 Inflammatory Bowel Diseases
"Inflammatory Bowel Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Descriptor ID |
D015212
|
| MeSH Number(s) |
C06.405.205.731 C06.405.469.432
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Bowel Diseases".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Bowel Diseases".
This graph shows the total number of publications written about "Inflammatory Bowel Diseases" by people in this website by year, and whether "Inflammatory Bowel Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 0 | 1 | | 1990 | 3 | 0 | 3 | | 1991 | 1 | 0 | 1 | | 1992 | 2 | 0 | 2 | | 1993 | 3 | 0 | 3 | | 1994 | 2 | 0 | 2 | | 1995 | 2 | 0 | 2 | | 1998 | 8 | 0 | 8 | | 1999 | 3 | 1 | 4 | | 2000 | 4 | 0 | 4 | | 2001 | 4 | 0 | 4 | | 2002 | 11 | 0 | 11 | | 2003 | 7 | 1 | 8 | | 2004 | 4 | 1 | 5 | | 2005 | 6 | 4 | 10 | | 2006 | 14 | 4 | 18 | | 2007 | 10 | 1 | 11 | | 2008 | 9 | 2 | 11 | | 2009 | 9 | 2 | 11 | | 2010 | 7 | 2 | 9 | | 2011 | 6 | 1 | 7 | | 2012 | 5 | 4 | 9 | | 2013 | 13 | 1 | 14 | | 2014 | 13 | 1 | 14 | | 2015 | 21 | 2 | 23 | | 2016 | 15 | 5 | 20 | | 2017 | 12 | 5 | 17 | | 2018 | 13 | 3 | 16 | | 2019 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Inflammatory Bowel Diseases" by people in Profiles.
-
Rankin CR, Lokhandwala ZA, Huang R, Pekow J, Pothoulakis C, Padua D. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation. Life Sci. 2019 Aug 15; 231:116571.
-
Graham WV, He W, Marchiando AM, Zha J, Singh G, Li HS, Biswas A, Ong MLDM, Jiang ZH, Choi W, Zuccola H, Wang Y, Griffith J, Wu J, Rosenberg HJ, Wang Y, Snapper SB, Ostrov D, Meredith SC, Miller LW, Turner JR. Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis. Nat Med. 2019 04; 25(4):690-700.
-
Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kivelevitch D, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Lim HW, Paller AS, Parra SL, Pathy AL, Prater EF, Rupani R, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019 Apr; 80(4):1073-1113.
-
Guandalini S, Sansotta N. Probiotics in the Treatment of Inflammatory Bowel Disease. Adv Exp Med Biol. 2019; 1125:101-107.
-
Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS. Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 11 29; 24(12):2634-2640.
-
Feld LD, Rubin DT, Feld AD. Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer. Am J Gastroenterol. 2018 11; 113(11):1577-1579.
-
Weisshof R, El Jurdi K, Zmeter N, Rubin DT. Emerging Therapies for Inflammatory Bowel Disease. Adv Ther. 2018 11; 35(11):1746-1762.
-
Harris KG, Chang EB. The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease. Clin Sci (Lond). 2018 09 28; 132(18):2013-2028.
-
McDonald BD, Jabri B, Bendelac A. Diverse developmental pathways of intestinal intraepithelial lymphocytes. Nat Rev Immunol. 2018 08; 18(8):514-525.
-
Jung D, Alshaikh A, Ratakonda S, Bashir M, Amin R, Jeon S, Stevens J, Sharma S, Ahmed W, Musch M, Hassan H. Adenosinergic signaling inhibits oxalate transport by human intestinal Caco2-BBE cells through the A2B adenosine receptor. Am J Physiol Cell Physiol. 2018 11 01; 315(5):C687-C698.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|